Prescribing pattern of drugs in alcohol dependence in a tertiary care hospital
Keywords:Alcohol dependence, Acamprosate, Baclofen, Benzodiazepines, Naltrexone
Background: Alcohol dependence is one of the more serious public health issues in the world. It not only affects health but is also a social and economic burden. Pharmacotherapy is the main stay of treatment along with behavioural therapy for alcohol addiction. The present study was done to analyse the prescribing pattern of drugs used in alcohol dependence.
Methods: The present study is a retrospective study which was carried out in the Department of Psychiatry, Dr. B.R. Ambedkar Medical College, Bengaluru from March 2016 to August 2016. Demographic, disease and treatment details were collected and entered in the case proformas. The results were analyzed using descriptive statistics.
Results: A total of 125 prescriptions were analyzed. The most common age group was between 30-60 years with a male predominance (95.2%). 72% of patients were treated for alcohol dependence whereas 28% who had other co morbidities like psychosis and depression were treated appropriately. The most commonly prescribed drugs were Vitamins (74.4%), Benzodiazepines (BZDs) (56.8%), anti-craving drugs (52%), antipsychotics (20%) and anti-depressant drugs (8%). Lorazepam (45.6%) and Baclofen (46.1%) were the most common drugs prescribed among BZDs and Anti-craving drugs respectively. For affective disorders Olanzapine (36%) was the commonest drug prescribed.
Conclusions: This study reveals that alcohol dependence is accompanied by other co-morbidities like psychosis, depression and anxiety. Combined therapy of Vitamins, BZDs, Anti-craving drugs along with Antipsychotic or Antidepressant drugs have been prescribed to the patients. Newer anti-craving drugs like Baclofen, Acamprosate and Naltrexone have also been prescribed.
World Health Organization, World Health Organization. Management of Substance Abuse Unit. Global status report on alcohol and health. World Health Organization; 2014.
Lancet’s Global Disease Burden Study 2010. thelancet.com
Gururaj G, Murthy P, Girish N, Benegal V. Alcohol related harm: Implications for public health and policy in India. Bangalore: NIMHANS. 2011.
Desouza A. Pharmacotherapy of alcohol dependence: A state of art review. Mens Sana Monogr. 2010 Jan-Dec;8(1):69-82.
Introduction to Drug Utilization Research, Geneva WHO, 2003.
Johnson BA, Ruiz P, Lippincott, William and Wilkins. Handbook of clinical alcohol treatment; 2003.
Chand P, Naveen CK, Murthy P, Isaac M. Addressing alcohol addiction: lessons from a hospital based audit. The Indian journal of medical research. 2013 Feb;137(2):394.
Bhanu PK. Prescribing patterns of drugs in patients with alcoholic liver disease in a tertiary care hospital. National journal of Physiology, Pharmacy and Pharmacology. 2017:7(5).
Hoey LL, Nahum A et al. A prospective evaluation of Benzodiazepine guidelines in management of patients hospitalized for alcohol withdrawal. PMID. 1994:579-585.
Ambekar A, Kattimani S. Anti-Craving Medications in the Treatment of Alcoholism.
Dupouy J, Fournier JP, Jouanjus É, Palmaro A, Poutrain JC, Oustric S, et al. Baclofen for alcohol dependence in France: incidence of treated patients and prescription patterns- a cohort study. European Neuropsychopharmacology. 2014 Feb 28;24(2):192-9.
Babu RS, Sengupta S. A study of problem drinkers in a general hospital. Indian J of psychiatry. 1997;39:13-7.
Lohit K. Factors affecting adherence to anti-craving medications. J Pharmacol Phamacother. 2016;7(2):72-9.
Ismene LP, Gerardo G, Robert R. Comorbidity of Alcoholism and Psychiatric Disorders. NIAAA.